CTRI/2017/09/009901招募中未知
Comparison of Formeterol Budesonide formulation nebulized alone and in combinated with ipratropium bromide in patients with COPD
Dr Juhi Singla0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. coming to Pulmonary medicine OPD
- •2. admitted in Pulmonary med Ward
排除标准
- •1. Cardiac Disease
- •2. Pregnancy
- •3. Diabetes mellitus
- •4. Malignancy
研究者
相似试验
尚未招募
不适用
To study effect of Vitamin D supplementation in asthma patientsCTRI/2021/09/036165Dr Preeti Navik
招募中
不适用
The clinical study of the budesonide/formoterol combination drug additional dosage in the perioperative period in a lung cancer patient with COPD.on-small cell lung cancer patients with COPD.JPRN-UMIN000011462Hamamatsu University School of Medicine40
已完成
不适用
Improved effects of Budesonide/Formoterol combination therapy (Symbicort) on the residual eosinophilic inflammation in the distal airways of asthmatic patients who used the salmeterol/fluticasone combination drugBronchial asthmaJPRN-UMIN000003805JA Tohno Kousei Hospital40
已完成
不适用
Effects of budesonide and formoterol combination on airway regulatory T cells in mild asthmaticsJPRN-UMIN000004275Division of respirology, neurology, and rheumatology, Department of medicine, Kurume University School of Medicine10
已完成
不适用
Study on the effects of the budesonide/formoterol combination formulation in improving airway inflammation and airway resistance in patients with bronchial asthmaPatients with bronchial asthma aged 20 years and older (males and females, outpatients and inpatients) being treated with an ICS (at a dose equivalent to FP 200-1000 mcg/day) and salmeterol 100 mcg/day in combination (either as two separate products or one combined product) for 3 months or longer with poor or inadequate controlJPRN-UMIN000006572Chiba-Hokusoh Hospital, Nippon Medical School80